Ads
related to: Pfizer and Prices
Search results
Which Pharmaceutical Company is the Best Investment?
GoBankingRates via AOL· 3 days agoAnalysts currently are projecting an average annual growth rate of 4.84% for JNJ over the next five years. Pfizer, on the other hand, is actually...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks· 21 hours agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish. It is scheduled to open in 2029.
Parents push Schumer to protect kids online
Politico· 12 hours agoPOLITICO’s Lisa Kashinsky, Kimberly Leonard and Brittany Gibson report that former President Donald Trump is escalating his rhetoric on vaccines. POLITICO...
GSK to Sell Remaining $1.6 Billion Stake in Haleon
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the...
BIO to restructure, lay off staff in shakeup of lobbying group
BioPharma Dive via Yahoo Finance· 11 hours agoIn recent months, Pfizer, Takeda Pharmaceuticals and UCB all left BIO, while others, including...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 15 hours agoAmgen Inc. price | Amgen Inc. Quote Our Take With the obesity market expected to grow at an...
Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their...
The Motley Fool· 2 days agoAre you famous enough for picking great stocks to become a billionaire money manager? The U.S....
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoAfter hitting a two-year high in February, biotech stocks sloughed off in April but have started to...
Vepdegestrant shows promise in breast cancer trial By Investing.com
Investing.com· 5 days agoArvinas, Inc. (NASDAQ: ARVN) and Pfizer Inc. (NYSE: NYSE:PFE) today announced continued positive...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 2 days agoNovavax is pursuing full approval for Nuvaxovid in the U.S. It will likely earn the nod, but how...
